๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Progress with Alemtuzumab in Chronic Lymphocytic Leukemia: Update from the 2003 Meeting of the American Society of Hematology

โœ Scribed by Lee, David; Jain, Vinay K.


Book ID
119615126
Publisher
CIG Media Group, LP.
Year
2004
Tongue
English
Weight
94 KB
Volume
4
Category
Article
ISSN
1526-9655

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Subcutaneous Alemtuzumab in Fludarabine-
โœ Stilgenbauer, S.; Zenz, T.; Winkler, D.; Buhler, A.; Schlenk, R. F.; Groner, S.; ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› American Society of Clinical Oncology ๐ŸŒ English โš– 170 KB

## Purpose The phase II CLL2H trial evaluated safety and efficacy of subcutaneous alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia (CLL). Clinical and biologic markers were evaluated for their impacts on outcome. ## Patients and Methods One hundred nine patients